Evidence map›Paper›PMID 35274475›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

A Vehicle-Free Antimicrobial Polymer Hybrid Gold Nanoparticle as Synergistically Therapeutic Platforms for Staphylococcus aureus Infected Wound Healing.

Xiaojun He, Lixiong Dai, Lisong Ye, Xiaoshuai Sun, Obeng Enoch, Rongdang Hu, Xingjie Zan, Feng Lin, Jianliang Shen

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Xiaojun HeSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Lixiong DaiWenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325000, China.
Lisong YeSchool of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Xiaoshuai SunSchool of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Obeng EnochSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Rongdang HuSchool of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Xingjie ZanSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.
Feng LinDepartment of gynecology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, China.
Jianliang ShenSchool of Ophthalmology & Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China.ORCID 0000-0003-4351-4872

Funding

National Natural Science Foundation of China 21977081National Natural Science Foundation of China 31800833University of Chinese Academy of Science WIBEZD2017001-03Wenzhou Medical University KYYW201901Wenzhou Science and Tenhnology Plan Projet ZG2021035Zhejiang Provincial Natural Science of Foundation of China LZ19H180001
6 · The paper itself

Abstract

Pathogenic bacteria infection is a serious threat to human public health due to the high morbidity and mortality rates. Nano delivery system for delivering antibiotics provides an alternative option to improve the efficiency compared to conventional therapeutic agents. In addition to the drug loading capacity of nanocarriers, which is typically around 10%, further lowers the drug dose that pathological bacteria are exposed to. Moreover, nanocarriers that are not eliminated from the body may cause side effects. These limitations have motivated the development of self-delivery systems that are formed by the self-assembly of different therapeutic agents. In this study, a vehicle-free antimicrobial polymer polyhexamethylene biguanide (PHMB, with bactericidal and anti-biofilm functions) hybrid gold nanoparticle (Au NPs, with photothermal therapy (PTT)) platform (PHMB@Au NPs) is developed. This platform exhibits an excellent synergistic effect to enhance the photothermal bactericidal effect for Staphylococcus aureus under near-infrared irradiation. Furthermore, the results showed that PHMB@Au NPs inhibit the formation of biofilms, quickly remove bacteria to promote wound healing through PTT in infection model in vivo, and even mediate the transition of macrophages from M1 to M2 type, and accelerate tissue angiogenesis. PHMB@Au NPs will have promising value as highly effective antimicrobial agents for patient management.

Indexed as

Metal NanoparticlesStaphylococcal InfectionsWound InfectionAnti-Bacterial AgentsBacteriaGoldHumansPolymersStaphylococcus aureusWound HealingAnti-Bacterial AgentsGoldPolymersanti-biofilmbactericidal effecthybrid gold nanoparticlespolyhexamethylene biguanidewound healing

Identifiers

PMID35274475
PMCPMC9108595

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.